Company
Blueprint Medicines
Pioneering the science of time
Also known as Blueprint Medicines Corporation
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Legal name
- Blueprint Medicines Corporation
- blueprintmedicines.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Every day, we seek to transform science into more time for life. Time to be with families, time to be active community members, time to feel the small moments of joy that shape our lives.
Funding snapshot
- Total raised
- $73.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $50M2014-11-10
Funding rounds
- Round, 2014
- $50M2014-11-10, SEC form D sold, 29 investors
- Round, 2014
- $23.2M2014-01-06, SEC form D sold, 10 investors
About the company
- Status notes
- Blueprint Medicines, a Sanofi Company
Products
- Other
- Avapritinib
- Other
- BLU-808
- Other
- Elenestinib
Loading relationship preview